Skip to content
Open access

Association Between Socioeconomic Position and Diagnosis, Treatment and Survival of Patients With Stage I-III Rectal Cancer in the Netherlands.

Jul 2026 · International Journal of Cancer · 0 citations · 36 references
Medicine

TL;DR

Although several disparities were partly explained by comorbidity and BMI, others persisted, highlighting the need for targeted strategies to reduce differences between SEP groups in rectal cancer management and outcomes.

Abstract

Socioeconomic position (SEP) influences cancer care and outcomes, even in countries with government-funded healthcare. This population-based study examined associations between SEP, rectal cancer care and survival of patients in the Netherlands. Data from 25,995 patients with Stage I-III rectal cancer diagnosed between 2015 and 2023 were obtained from the Netherlands Cancer Registry. SEP was categorised as lower, intermediate or higher using income-based postal code data. Associations between SEP and detection method, treatments, and outcomes were analysed using multivariable logistic regression. Relative survival and relative excess risk (RER) of death were calculated using a generalised linear model. Compared to lower SEP, higher SEP patients were younger (median age 66 vs. 71 years), more often male (65% vs. 59%), had better performance status (71% vs. 52% PS0), fewer comorbidities (63% vs. 50% CCI 0) and lower obesity rates (15% vs. 23%). Higher rates of Stage I tumours (34% vs. 30%), screen-detection (45% vs. 38%), laparoscopic surgery use (93% vs. 90%), and lower rates of colostomies (64% vs. 71%) and adverse in-hospital outcomes (44% vs. 55%) were observed among higher SEP patients (all p < 0.001). Five-year relative survival improved with increasing SEP (79.5% lower, 82.4% intermediate, 84.9% higher SEP; p < 0.001), with lower excess mortality for higher SEP patients (RER 0.90, 95% CI 0.81-0.99). SEP-related differences were observed in screening, stage at diagnosis, surgical treatment and survival. Although several disparities were partly explained by comorbidity and BMI, others persisted, highlighting the need for targeted strategies to reduce differences between SEP groups in rectal cancer management and outcomes.

Read PDF

Similar papers

Review Open access Sep 2026

Survival outcome of Gallbladder cancer in the US: An updated surveillance, epidemiology, and end results-based analysis of age and gender disparities

Male gender, older age, and distant tumor stage are significant predictors of higher mortality, while chemotherapy and surgery substantially improve survival in GBC patients, highlighting the necessity for targeted interventions and personalized treatment approaches to enhance survival rates.

Ayrton I. Bangolo, Behzad Amoozgar, B. Alqinai et al. · 0 citations
Review Open access Aug 2026

Treatment strategies and oncological outcomes across national guideline periods in rectal cancer: a population-based cohort study

The findings support a more selective radiotherapy use while maintaining oncological safety and reducing treatment-related morbidity in patients with clinical stage I–III rectal cancer treated with curative intent.

S. Doroudian, E. Osterman, B. Glimelius · 0 citations
Open access Aug 2026

Socioeconomic disparities in survival of patients with superficial colorectal cancer

Limited data are available regarding the impact of socioeconomic disparities on the survival of patients with superficial colorectal cancer (SCRC). We used population-based data from the U.S. Surveillance, Epidemiology, and End Results (SEER) program registry to conduct a retrospective cohort study to examine the impac...

Shuo Chen, Shuang Zhao, Jing-Tao Li et al. · 0 citations
Open access Sep 2026

Cancer Patients Mortality From Other Causes: A European Population‐Based Study

Cancer patients may face elevated mortality not only from their malignancy but also from other factors including multi‐morbidity and the impact of treatment‐related complications. This study analyses mortality from all causes other than the index cancer among cancer patients compared to the general population.

Gemma Gatta, R. Capocaccia, S. Rossi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.